Effect of Fcγ-receptor 3a (<i>FCGR3A</i>) gene polymorphisms on rituximab therapy in Hungarian patients with rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1136/rmdopen-2017-000485
Published Online: 2017-11-01
Published Print: 2017-11
Update policy: https://doi.org/10.1136/crossmarkpolicy
Pál, Ildikó
Szamosi, Szilvia
Hodosi, Katalin
Szekanecz, Zoltan
Váróczy, László
Funding for this research was provided by:
European Union
European Union, European Social Fund
